Rivopharm is a Swiss-based company focused on the development, manufacture and marketing of pharmaceutical products in the generic field at a global level.
Characterized by a highly experienced team and innovative technologies, the Rivopharm Group continues its expansion year after year, delivering high-quality and customer-oriented services to its partners. Our broad and diverse portfolio of high quality and niche products counts over a 100 molecules, with more than 2000 SKUs, covering a wide range of therapeutic areas.
Rivopharm aims to a continuous expansion selecting strategical projects in cooperation with its highly-qualified R&D team, and it is now present, directly and through its associates and partners, in more than 60 countries around the world.
- Industial prodution of oral dosages forms
- analytical development and validation
- Direct marketing in selected countries
- Development of pharmaceutical formulation
- Process development and validation
- QC analysis and release
- Packaging of pharmaceutical oral dosages forms in blisters and/or bottles
- Registration via national submission or DCP procedure